These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 25605650)

  • 1. CXCL10/IP-10 is a biomarker and mediator for Kawasaki disease.
    Ko TM; Kuo HC; Chang JS; Chen SP; Liu YM; Chen HW; Tsai FJ; Lee YC; Chen CH; Wu JY; Chen YT
    Circ Res; 2015 Feb; 116(5):876-83. PubMed ID: 25605650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
    Ye Q; Shao WX; Shang SQ; Zhang T; Hu J; Zhang CC
    Arthritis Rheumatol; 2015 Jul; 67(7):1943-50. PubMed ID: 25778686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
    Sato S; Kawashima H; Kashiwagi Y; Hoshika A
    Int J Rheum Dis; 2013 Apr; 16(2):168-72. PubMed ID: 23773640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokines in Kawasaki disease: measurement of CCL2, CCL22 and CXCL10.
    Shikishima Y; Saeki T; Matsuura N
    Asian Pac J Allergy Immunol; 2003 Sep; 21(3):139-43. PubMed ID: 15032397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition.
    Li Y; Zheng Q; Zou L; Wu J; Guo L; Teng L; Zheng R; Jung LKL; Lu M
    Pediatr Rheumatol Online J; 2019 Jan; 17(1):1. PubMed ID: 30611297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoprotegerin serum levels in Kawasaki disease: an additional potential marker in predicting children with coronary artery involvement.
    Simonini G; Masi L; Giani T; Piscitelli E; Cimaz R; Vierucci S; Brandi ML; Falcini F
    J Rheumatol; 2005 Nov; 32(11):2233-8. PubMed ID: 16265708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
    Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H
    Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
    Peng Q; Wu Q; Chen CH; Hong H; Zhang LY
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
    Ge X; Li CR; Yang J; Wang GB
    Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated Levels of Platelet Activating Factor and Its Acetylhydrolase Indicate High Risk of Kawasaki Disease.
    Yi L; Zhang J; Zhong J; Zheng Y
    J Interferon Cytokine Res; 2020 Mar; 40(3):159-167. PubMed ID: 31841639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers.
    Rothenbacher D; Müller-Scholze S; Herder C; Koenig W; Kolb H
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):194-9. PubMed ID: 16239601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel data-mining approach identifies biomarkers for diagnosis of Kawasaki disease.
    Tremoulet AH; Dutkowski J; Sato Y; Kanegaye JT; Ling XB; Burns JC
    Pediatr Res; 2015 Nov; 78(5):547-53. PubMed ID: 26237629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased CD11b expression on polymorphonuclear leucocytes and cytokine profiles in patients with Kawasaki disease.
    Kobayashi T; Kimura H; Okada Y; Inoue Y; Kobayashi T; Shinohara M; Morikawa A
    Clin Exp Immunol; 2007 Apr; 148(1):112-8. PubMed ID: 17286760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of intra- and extracellular heat shock protein 60 in Kawasaki disease patients treated with intravenous immunoglobulin.
    Yin Ji X; Kang MR; Choi JS; Jeon HS; Han HS; Kim JY; Son BR; Lee YM; Hahn YS
    Clin Immunol; 2007 Sep; 124(3):304-10. PubMed ID: 17602873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of chemokines in Kawasaki disease, Henoch-Schönlein purpura and acute febrile illness.
    Chung HS; Kim HY; Kim HS; Lee HJ; Yuh JH; Lee ES; Choi KH; Lee YH
    J Korean Med Sci; 2004 Dec; 19(6):800-4. PubMed ID: 15608388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
    Wang Y; Wang W; Gong F; Fu S; Zhang Q; Hu J; Qi Y; Xie C; Zhang Y
    Arthritis Rheum; 2013 Mar; 65(3):805-14. PubMed ID: 23440694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do cytokines correlate with refractory Kawasaki disease in children?
    Wang Y; Qian SY; Yuan Y; Wang Q; Gao L; Chen X; Yu X; Zhen Z
    Clin Chim Acta; 2020 Jul; 506():222-227. PubMed ID: 32156603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine and chemokine receptor analysis reveals elevated interferon-inducible protein-10 (IP)-10/CXCL10 levels and increased number of CCR5+ and CXCR3+ CD4 T cells in synovial fluid of patients with enthesitis-related arthritis (ERA).
    Aggarwal A; Agarwal S; Misra R
    Clin Exp Immunol; 2007 Jun; 148(3):515-9. PubMed ID: 17374135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum soluble E-selectin levels in Kawasaki disease.
    Kim DS; Lee KY
    Scand J Rheumatol; 1994; 23(5):283-6. PubMed ID: 7526448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant laboratory marker of Kawasaki disease; NT-pro-BNP or hs-CRP?
    Cho SY; Kim Y; Cha SH; Suh JT; Han MY; Lee HJ
    Ann Clin Lab Sci; 2011; 41(4):360-3. PubMed ID: 22166506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.